Harrow, Inc. Increase (Decrease) in Deferred Revenue
Harrow, Inc. (HROW) reported Increase (Decrease) in Deferred Revenue of -$682.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-10
- Harrow, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was -$43.00K.
- Harrow, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$639.00K, a 732.67% decline year-over-year.
- Harrow, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was $443.00K.
- Harrow, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $254.00K.
- Harrow, Inc. increase (decrease) in deferred revenue for fiscal 2025 was $744.00K.
- Harrow, Inc. increase (decrease) in deferred revenue for fiscal 2024 was -$31.00K.
- Harrow, Inc. increase (decrease) in deferred revenue for fiscal 2023 was -$38.00K.
- Harrow, Inc. increase (decrease) in deferred revenue for fiscal 2012 was -$100.00K, a 600.00% decline from fiscal 2011.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 155 month | Increase (Decrease) in Deferred Revenue 158 month | Increase (Decrease) in Deferred Revenue 161 month | Increase (Decrease) in Deferred Revenue 164 month | Increase (Decrease) in Deferred Revenue 173 month | Increase (Decrease) in Deferred Revenue 176 month | Increase (Decrease) in Deferred Revenue 182 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$682.00K 10-Q · filed 2026-08-10 | -$239.00K derived: sum of 3 quarters · filed 2026-08-10 | $15.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||||
| 2026-03-31 | -$639.00K 10-Q · filed 2026-05-11 | -$196.00K derived: sum of 2 quarters · filed 2026-05-11 | $58.00K derived: sum of 3 quarters · filed 2026-05-11 | $4.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||||
| 2025-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $697.00K derived: sum of 2 quarters · filed 2026-03-02 | $643.00K derived: sum of 3 quarters · filed 2026-08-10 | $744.00K 10-K · filed 2026-03-02 | |||||||
| 2025-09-30 | $254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $200.00K derived: sum of 2 quarters · filed 2026-08-10 | $301.00K 10-Q · filed 2025-11-10 | $208.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||||
| 2025-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $47.00K 10-Q · filed 2026-08-10 | -$46.00K derived: sum of 3 quarters · filed 2026-08-10 | -$157.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||||
| 2025-03-31 | $101.00K 10-Q · filed 2026-05-11 | $8.00K derived: sum of 2 quarters · filed 2026-05-11 | -$103.00K derived: sum of 3 quarters · filed 2026-05-11 | $33.00K derived: sum of 4 quarters · filed 2026-05-11 | |||||||
| 2024-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$204.00K derived: sum of 2 quarters · filed 2026-03-02 | -$68.00K derived: sum of 3 quarters · filed 2026-03-02 | -$31.00K 10-K · filed 2026-03-02 | |||||||
| 2024-09-30 | -$111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $25.00K derived: sum of 2 quarters · filed 2025-11-10 | $62.00K 10-Q · filed 2025-11-10 | ||||||||
| 2024-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $173.00K 10-Q · filed 2025-08-11 | |||||||||
| 2024-03-31 | $37.00K 10-Q · filed 2025-05-08 | ||||||||||
| 2023-12-31 | -$38.00K 10-K · filed 2026-03-02 | ||||||||||
| 2013-09-30 | $833.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $1.67K derived: sum of 2 quarters · filed 2014-11-12 | $2.50K 10-Q · filed 2014-11-12 | $2.50K derived: sum of 4 quarters · filed 2014-11-12 | $2.50K 10-Q · filed 2013-11-06 | ||||||
| 2013-06-30 | $834.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $1.67K 10-Q · filed 2014-08-13 | $1.67K derived: sum of 3 quarters · filed 2014-08-13 | $1.67K derived: sum of 4 quarters · filed 2014-08-13 | $1.67K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $833.00 10-Q · filed 2014-05-15 | $833.00 derived: sum of 2 quarters · filed 2014-05-15 | $833.00 derived: sum of 3 quarters · filed 2014-05-15 | $833.00 derived: sum of 4 quarters · filed 2014-05-15 | $833.00 10-Q · filed 2013-05-08 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | -$100.00K 10-K · filed 2014-03-28 | $0.00 10-K · filed 2013-03-18 | ||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | -$100.00K 10-Q · filed 2013-11-06 | -$100.00K derived: sum of 4 quarters · filed 2013-11-06 | |||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$100.00K 10-Q · filed 2013-08-14 | -$100.00K derived: sum of 3 quarters · filed 2013-08-14 | -$100.00K derived: sum of 4 quarters · filed 2013-08-14 | |||||||
| 2012-03-31 | -$100.00K 10-Q · filed 2013-05-08 | -$100.00K derived: sum of 2 quarters · filed 2013-05-08 | -$100.00K derived: sum of 3 quarters · filed 2013-05-08 | -$80.00K derived: sum of 4 quarters · filed 2013-05-08 | $0.00 10-Q · filed 2012-05-10 | ||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $20.00K derived: sum of 3 quarters · filed 2013-03-18 | $20.00K 10-K · filed 2013-03-18 | $100.00K 10-K · filed 2012-02-23 | ||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $20.00K derived: sum of 2 quarters · filed 2012-11-14 | $20.00K 10-Q · filed 2012-11-14 | $100.00K derived: sum of 4 quarters · filed 2012-11-14 | $100.00K 10-Q · filed 2012-02-23 | ||||||
| 2011-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $20.00K 10-Q · filed 2012-08-14 | $100.00K derived: sum of 3 quarters · filed 2012-08-14 | $100.00K derived: sum of 4 quarters · filed 2012-08-14 | $100.00K 10-Q · filed 2012-02-23 | ||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | $80.00K derived: sum of 2 quarters · filed 2012-05-10 | $80.00K derived: sum of 3 quarters · filed 2012-05-10 | ||||||||
| 2010-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $80.00K derived: sum of 2 quarters · filed 2012-02-23 | $80.00K 10-K · filed 2012-02-23 | ||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | |||||||||
| 2010-06-30 | $0.00 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |